United Therapeutics (UTHR) Tax Rate Growth (1y) (2010 - 2026)
Powered by 
Analysis
United Therapeutics (UTHR) Tax Rate Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,356.00 |
| Mar 31, 2026 | -1,028.00 |
| Dec 31, 2025 | -606.00 |
| Sep 30, 2025 | 221.00 |
| Jun 30, 2025 | 249.00 |
| Mar 31, 2025 | 84.00 |
| Dec 31, 2024 | -250.00 |
| Sep 30, 2024 | -348.00 |
| Jun 30, 2024 | -94.00 |
| Mar 31, 2024 | 561.00 |
| Dec 31, 2023 | 39.00 |
| Sep 30, 2023 | 51.00 |
| Jun 30, 2023 | -30.00 |
| Mar 31, 2023 | -482.00 |
| Dec 31, 2022 | 598.00 |
| Sep 30, 2022 | 302.00 |
| Jun 30, 2022 | 270.00 |
| Mar 31, 2022 | 936.00 |
| Dec 31, 2021 | 651.00 |
| Sep 30, 2021 | -143.00 |